279 related articles for article (PubMed ID: 6577582)
1. Clinical aspects of continuous ambulatory peritoneal dialysis.
Grefberg N
Scand J Urol Nephrol Suppl; 1983; 72():1-46. PubMed ID: 6577582
[TBL] [Abstract][Full Text] [Related]
2. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
3. Treatment of resistant CAPD peritonitis by temporary discontinuation of peritoneal dialysis.
Cairns HS; Beckett J; Rudge CJ; Thompson FD; Mansell MA
Clin Nephrol; 1989 Jul; 32(1):27-30. PubMed ID: 2489022
[TBL] [Abstract][Full Text] [Related]
4. [Continuous ambulatory peritoneal dialysis in diabetic patients].
Stojimrović B; Nesić V
Srp Arh Celok Lek; 1998; 126(7-8):277-82. PubMed ID: 9863395
[TBL] [Abstract][Full Text] [Related]
5. Extended spectrum beta-lactamase-producing Klebsiella pneumoniae chronic ambulatory peritoneal dialysis peritonitis treated successfully with polymyxin B.
Parchuri S; Mohan S; Cunha BA
Heart Lung; 2005; 34(5):360-3. PubMed ID: 16157192
[TBL] [Abstract][Full Text] [Related]
6. Treatment of recurrent and resistant CAPD peritonitis by temporary withdrawal of peritoneal dialysis without removal of the catheter.
Locatelli A; Quiroga MA; De Benedetti L; Gomez M; Barone R; Barron MC
Adv Perit Dial; 1995; 11():176-8. PubMed ID: 8534698
[TBL] [Abstract][Full Text] [Related]
7. Peritonitis in type 2 diabetes mellitus due to Ochrobactrum anthropi complicating automated peritoneal dialysis.
Sepe V; Esposito P; Sacco L; Ceci A; Magrassi A; Negri MT; Libetta C; Dal Canton A
Acta Diabetol; 2010 Dec; 47(4):341-4. PubMed ID: 20563608
[TBL] [Abstract][Full Text] [Related]
8. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
[TBL] [Abstract][Full Text] [Related]
9. [Continuous ambulatory peritoneal dialysis in children. 2 years' experience].
Heller-Ackeret C; Ertelt W; Leumann EP
Schweiz Med Wochenschr; 1982 Jun; 112(24):859-64. PubMed ID: 7051275
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis.
Krothapalli R; Duffy WB; Lacke C; Payne W; Patel H; Perez V; Senekjian HO
Arch Intern Med; 1982 Oct; 142(10):1862-3. PubMed ID: 6812523
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002).
Kavanagh D; Prescott GJ; Mactier RA
Nephrol Dial Transplant; 2004 Oct; 19(10):2584-91. PubMed ID: 15304559
[TBL] [Abstract][Full Text] [Related]
12. Fungal peritonitis in patients on peritoneal dialysis: twenty five years of experience in a teaching hospital in Argentina.
Predari SC; de Paulis AN; Verón D; Zucchini A; Santoianni JE
Rev Argent Microbiol; 2007; 39(4):213-7. PubMed ID: 18390154
[TBL] [Abstract][Full Text] [Related]
13. Hydrothorax in a patient receiving continuous ambulatory peritoneal dialysis: successful treatment with intermittent peritoneal dialysis.
Townsend R; Fragola JA
Arch Intern Med; 1982 Aug; 142(8):1571-2. PubMed ID: 7103642
[TBL] [Abstract][Full Text] [Related]
14. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
[TBL] [Abstract][Full Text] [Related]
15. Acinetobacter peritonitis in patients receiving continuous ambulatory peritoneal dialysis.
Valdez JM; Asperilla MO; Smego RA
South Med J; 1991 May; 84(5):607-10. PubMed ID: 2035081
[TBL] [Abstract][Full Text] [Related]
16. Continuous ambulatory peritoneal dialysis (CAPD).
Swartz RD
Compr Ther; 1983 Aug; 9(8):54-60. PubMed ID: 6617129
[No Abstract] [Full Text] [Related]
17. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of hydrothorax complicating continuous ambulatory peritoneal dialysis.
Pattison CW; Rodger RS; Adu D; Michael J; Matthews HR
Clin Nephrol; 1984 Mar; 21(3):191-3. PubMed ID: 6705282
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and cause of removal of peritoneal dialysis catheter in patients on continuous ambulatory peritoneal dialysis.
Nodaira Y; Ikeda N; Kobayashi K; Watanabe Y; Inoue T; Gen S; Kanno Y; Nakamoto H; Suzuki H
Adv Perit Dial; 2008; 24():65-8. PubMed ID: 18986004
[TBL] [Abstract][Full Text] [Related]
20. [Peritonitis in continuous ambulatory peritoneal dialysis: diagnosis and treatment].
Bénévent D; Lagarde C; Benzakour M
Nephrologie; 1989; 10 Suppl():43-5. PubMed ID: 2682310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
